Stockscreener 앱 받기
2.72
2.64%
0.07
전일 마감가:
$2.65
열려 있는:
$2.67
하루 거래량:
92,182
Relative Volume:
0.80
시가총액:
$13.40M
수익:
-
순이익/손실:
$-43.10M
주가수익비율:
-0.2798
EPS:
-9.7212
순현금흐름:
$-36.82M
1주 성능:
-5.88%
1개월 성능:
-6.53%
6개월 성능:
-59.22%
1년 성능:
-76.63%
1일 변동 폭
$2.62
$2.78
1주일 범위
$2.40
$2.92
52주 변동 폭
$2.40
$13.13
Tempest Therapeutics Inc Stock (TPST) Company Profile
명칭
Tempest Therapeutics Inc
전화
415-798-8589
주소
2000 SIERRA POINT PARKWAY, BRISBANE
TPST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
2.72 | 13.06M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-08 | 개시 | Jefferies | Buy |
Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스
Is Tempest Therapeutics Incs growth already priced inWeekly Trend Recap & Daily Profit Focused Screening - baoquankhu1.vn
Published on: 2026-01-13 20:12:45 - Bộ Nội Vụ
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance By Investing.com - Investing.com Canada
Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting - TipRanks
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance - Investing.com
Tempest Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Why retail investors favor Tempest Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - Улправда
Will Tempest Therapeutics Inc. stock pay special dividendsJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - Улправда
Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Update & Fast Momentum Stock Entry Tips - Улправда
Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent
Market Outlook: Will Tempest Therapeutics Inc stock pay special dividendsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - moha.gov.vn
Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga
Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com
How sustainable is Tempest Therapeutics Inc. stock dividend payout2025 Winners & Losers & Verified Momentum Stock Alerts - Улправда
Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com India
Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener
Tempest Therapeutics closes $4.25 million registered direct offering - Investing.com
Tempest Therapeutics : Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - MarketScreener
Tempest Therapeutics, Inc. Completes Registered Direct Offering and Private Placement, Raising Approximately $4.25 Million - Quiver Quantitative
Tempest Announces Closing of Up To $8.35 Million Registered - GlobeNewswire
[8-K] Tempest Therapeutics, Inc. Reports Material Event | TPST SEC FilingForm 8-K - Stock Titan
Form 8-KCurrent report - ADVFN
Tempest Therapeutics stock falls after $4.25 million direct offering - MSN
[424B5] Tempest Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Form 424B5 Tempest Therapeutics, - StreetInsider
Tempest Therapeutics stock falls after $4.25 million direct offering By Investing.com - Investing.com UK
Tempest Therapeutics raises $4.25 million in registered direct offering - Investing.com
Tempest Therapeutics Inc (TPST) Performance and Fundamentals Dashboard tells a completely different story - setenews.com
Tempest Therapeutics raises $4.25 million in registered direct offering By Investing.com - Investing.com India
Tempest Therapeutics (Nasdaq: TPST) prices $4.25M offering with $4.1M warrant upside - Stock Titan
Tempest Therapeutics announces $8.35M registered direct offering, concurrent private placement - MSN
Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading - Nasdaq
Is Tempest Therapeutics Inc. stock ready for breakoutMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
Will Tempest Therapeutics Inc. stock outperform growth indexesTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Tempest Therapeutics Announces New Leadership and Acquisition - MSN
Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs By Investing.com - Investing.com Australia
Check Out Tempest Therapeutics Inc (TPST)’s Trade Data Rather Than the Analysts’ Views - Setenews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
What technical signals suggest for Tempest Therapeutics Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Will Tempest Therapeutics Inc. stock go up soonProduct Launch & Safe Entry Trade Signal Reports - newser.com
Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition - Markets Financial Content
Tempest gains CAR Ts for 65% of the company; stock drops - BioWorld MedTech
Why Tempest Therapeutics Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Tempest Therapeutics to acquire Factor Bioscience's CAR-T programs By Investing.com - Investing.com Nigeria
Is Tempest Therapeutics Inc. stock poised for growthWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Tempest Therapeutics Inc (TPST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):